Intertemporal choice in Parkinson's disease

Movement Disorders

Volumn 26, Issue 11, 2011, Pages 2004-2010

  Milenkova, Maria ^a,b   Mohammadi, Bahram ^c   Kollewe, Katja ^a   Schrader, Christoph ^a   Fellbrich, Anja ^a   Wittfoth, Matthias ^a   Dengler, Reinhard ^a   Münte, Thomas F ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Delay discounting; Dopamine agonists; Intertemporal choice; Parkinson's disease; Pathological gambling; Risk taking

Indexed keywords

PIRIBEDIL; PRAMIPEXOLE; ROPINIROLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECISION MAKING; FEMALE; HUMAN; IMPULSIVENESS; MALE; MONEY; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; REWARD;

AGED; CHOICE BEHAVIOR; DOPAMINE AGONISTS; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; REWARD;

EID: 80052961115     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23756     Document Type: Article

References (61)

1. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord. 2007; 22: 1757-1763.
2. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol. 2007; 64: 1089-1096.
3. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord. 2006; 21: 524-529.
4. Evans AH, Strafella AP, Weintraub D, Stacy M. Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord. 2009; 24: 1561-1570.
5. O'Sullivan SS, Evans AH, Lees AJ. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS Drugs. 2009; 23: 157-170.
6. Weintraub D. Dopamine and impulse control disorders in Parkinson's disease. Ann Neurol. 2008; 64(Suppl 2): S93-S100.
7. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol. 2006; 63: 969-973.
8. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010; 67: 589-595.
9. Grant JE, Chamberlain SR, Odlaug BL, Potenza MN, Kim SW. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl). 2010; 212: 603-612.
10. McClure SM, Laibson DI, Loewenstein G, Cohen JD. Separate neural systems value immediate and delayed monetary rewards. Science. 2004; 306: 503-507.
11. Kirby KN, Petry NM, Bickel WK. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen. 1999; 128: 78-87.
12. Petry NM. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J Abnorm Psychol. 2001; 110: 482-487.
13. Alessi SM, Petry NM. Pathological gambling severity is associated with impulsivity in a delay discounting procedure. Behav Processes. 2003; 64: 345-354.
14. Frederick S, Loewenstein G, O'Donoghue T. Time discounting and time preference: a critical review. In: Loewenstein G, Read D, Baumeister R, eds. New York, NY: Sage; 2003: 13-86.
15. Mazur JE. Tests of an equivalence rule for fixed and variable reinforcer delays. J Exp Psychol Anim Behav Process. 1984; 10: 426-436.
16. Kirby KN, Petry NM. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction. 2004; 99: 461-471.
17. Reynolds B. Do high rates of cigarette consumption increase delay discounting? A cross-sectional comparison of adolescent smokers and young-adult smokers and nonsmokers. Behav Processes. 2004; 67: 545-549.
18. Reynolds B, Richards JB, Horn K, Karraker K. Delay discounting and probability discounting as related to cigarette smoking status in adults. Behav Processes. 2004; 65: 35-42.
19. Mitchell JM, Fields HL, D'Esposito M, Boettiger CA. Impulsive responding in alcoholics. Alcohol Clin Exp Res. 2005; 29: 2158-2169.
20. Petry NM. Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology (Berl). 2001; 154: 243-250.
21. Kirby KN. The present values of delayed rewards are approximately additive. Behav Processes. 2006; 72: 273-282.
22. Marco-Pallares J, Mohammadi B, Samii A, Münte TF. Brain activations reflect individual discount rates in intertemporal choice. Brain Res. 2010; 1320: 123-129.
23. Beck AT, Steer RA, Brown GK. Beck Depression Inventory-Second Edition Manual. San Antonio, TX: The Psychological Corporation; 1996.
24. Kalbe E, Calabrese P, Kohn N, et al. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord. 2008; 14: 93-101.
25. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967; 17: 427-442.
26. Voon V, Hassan K, Zurowski M, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology. 2006; 67: 1254-1257.
27. Grosset K, Needleman F, Macphee G, Grosset D. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Mov Disord. 2004; 19: 1370-1374.
28. Goetz CG, Blasucci L, Stebbins GT. Switching dopamine agonists in advanced Parkinson's disease. Is rapid titration preferable to slow? Neurology. 1999; 52: 1227-1229.
29. Werheid K, Hoppe C, Thone A, Muller U, Mungersdorf M, von Cramon DY. The Adaptive Digit Ordering Test: clinical application, reliability, and validity of a verbal working memory test. Arch Clin Neuropsychol. 2002; 17: 547-565.
30. Aschenbrenner S, Tucha O, Lange KW. Regensburger Wortflüssigkeits Test (RWT). Göttingen: Hogrefe; 2000.
31. Bäumler G. Farbe-Wort-Interferenztest (FWIT). Göttingen: Hogrefe, 1985.
32. Niemann H, Köhler S, Sturm S, Willmes K, Gottland S, Saß C. Der California Verbal Learning Test (CVLT): daten zu einer autorisierten deutschen Version. Z Neuropsychol. 1999; 10: 220-221.
33. Sturm W, Willmes K, Horn W. Leistungsprüfsystem für 50-90 jährige (LPS 50+). Göttingen: Hogrefe; 1993.
34. Zimmermann P, Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (TAP). Version 1.7. Herzogenrath: PsyTest; 2002.
35. Miedl SF, Wiswede D, Marco-Pallares J, et al. The neural basis of impulsive discounting in pathological gamblers. PLoS One, submitted.
36. Mimura M, Oeda R, Kawamura M. Impaired decision-making in Parkinson's disease. Parkinsonism Relat Disord. 2006; 12: 169-175.
37. Pagonabarraga J, Garcia-Sanchez C, Llebaria G, Pascual-Sedano B, Gironell A, Kulisevsky J. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord. 2007; 22: 1430-1435.
38. Setlow B, Mendez IA, Mitchell MR, Simon NW. Effects of chronic administration of drugs of abuse on impulsive choice (delay discounting) in animal models. Behav Pharmacol. 2009; 20: 380-389.
39. Dallery J, Locey ML. Effects of acute and chronic nicotine on impulsive choice in rats. Behav Pharmacol. 2005; 16: 15-23.
40. Münte TF, Ye Z, Marco-Pallarés M, Krämer UM, et al. Dopamine and intertemporal choice in humans. Psychopharmacology, in revision.
41. Housden CR, O'Sullivan SS, Joyce EM, Lees AJ, Roiser JP. Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology. 2010; 35: 2155-2164.
42. Kirby KN. One-year temporal stability of delay-discount rates. Psychon Bull Rev. 2009; 16: 457-462.
43. Simpson CA, Vuchinich RE. Reliability of a measure of temporal discounting. Psychol Rec. 2000; 50: 3-16.
44. Baker F, Johnson MW, Bickel WK. Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude. J Abnorm Psychol. 2003; 112: 382-392.
45. Johnson MW, Bickel WK, Baker F. Moderate drug use and delay discounting: a comparison of heavy, light, and never smokers. Exp Clin Psychopharmacol. 2007; 15: 187-194.
46. Ohmura Y, Takahashi T, Kitamura N, Wehr P. Three-month stability of delay and probability discounting measures. Exp Clin Psychopharmacol. 2006; 14: 318-328.
47. Robert G, Drapier D, Verin M, Millet B, Azulay JP, Blin O. Cognitive impulsivity in Parkinson's disease patients: assessment and pathophysiology. Mov Disord. 2009; 24: 2316-2327.
48. Takahashi T, Ikeda K, Hasegawa T. A hyperbolic decay of subjective probability of obtaining delayed rewards. Behav Brain Funct. 2007; 3.
49. Simon NW, Mendez IA, Setlow B. Cocaine exposure causes long-term increases in impulsive choice. Behav Neurosci. 2007; 121: 543-549.
50. Marota JJ, Mandeville JB, Weisskoff RM, Moskowitz MA, Rosen BR, Kosofsky BE. Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rat. Neuroimage. 2000; 11: 13-23.
51. Dixon AL, Prior M, Morris PM, Shah YB, Joseph MH, Young AM. Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology. 2005; 48: 236-245.
52. Hariri AR, Brown SM, Williamson DE, Flory JD, de Wit H, Manuck SB. Preference for immediate over delayed rewards is associated with magnitude of ventral striatal activity. J Neurosci. 2006; 26: 13213-13217.
53. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology. 2009; 56(Suppl 1): 3-8.
54. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol. 2007; 64: 1575-1579.
55. Reuter J, Raedler T, Rose M, Hand I, Gläscher J, Büchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci. 2005; 8: 147-148.
56. Potenza MN, Steinberg MA, Skudlarski P, et al. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry. 2003; 60: 828-836.
57. Riba J, Kramer UM, Heldmann M, Richter S, Münte TF. Dopamine agonist increases risk taking but blunts reward-related brain activity. PLoS One. 2008; 3: e2479.
58. Ye Z, Hammer A, Camara E, Münte TF. Pramipexole modulates the neural network of reward anticipation. Hum Brain Mapp. 2010 [Epub ahead of print].
59. Knutson B, Adams CM, Fong GW, Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci. 2001; 21: RC159.
60. Bickel WK, Yi R. Temporal discounting as a measure of executive function: insights from the competing neuro-behavioral decision system hypothesis of addiction. Adv Health Econ Health Serv Res. 2008; 20: 289-309.
61. Voon V, Reynolds B, Brezing C, et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl). 2010; 207: 645-659.